Arsenicals are epidemiologically significant chemicals in relation to induction of
liver cancer in man. In the present study, we investigated the dose-dependent promotion potential of
dimethylarsinic acid (
DMAA), a major metabolite of inorganic
arsenicals in mammals, in a rat liver
carcinogenesis model. In experiment 1,
glutathione-S-transferase placental form (GST-P)-positive foci, putative preneoplastic lesions, were employed as endpoints of a liver medium-term bioassay for
carcinogens (Ito test). Starting 2 weeks after initiation with
diethylnitrosamine, male F344 rats were treated with 0, 25, 50 or 100 ppm of
DMAA in the
drinking water for 6 weeks. All animals underwent two-thirds partial
hepatectomy at week 3 after initiation. Examination of liver sections after termination at 8 weeks revealed dose-dependent increases in the numbers and areas of GST-P-positive foci in
DMAA-treated rats as compared with controls. In experiment 2,
ornithine decarboxylase activity, which is a
biomarker of cell proliferation, was found to be significantly increased in the livers of rats treated with
DMAA. In experiment 3, formation of
8-hydroxydeoxyguanosine, which is a marker of
oxygen radical-mediated DNA damage, was significantly increased after administration of
DMAA. These results indicate that
DMAA has the potential to promote rat liver
carcinogenesis, possibly via a mechanism involving stimulation of cell proliferation and DNA damage caused by
oxygen radicals.